Is a complete GOSS research report available?

No complete published report is available for Gossamer Bio, Inc. (GOSS) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Gossamer Bio, Inc. (GOSS)

NASDAQ: GOSS · USD

$0.18

-0.03 (-13.7%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first GOSS analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	87.2M
Revenue (ttm)	55.5M
Net income (ttm)	-180.4M
EPS (ttm)	-$0.78
Shares out	488.8M
Volume	30,642,605
Beta	2.04
Price target	$3.86	+2064.9%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 55.5M
Net income (ttm): -180.4M
EPS (ttm): -$0.78
Market cap: 87.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All GOSS indicators

Market & fundamental data

Available fields

206

Groups with data

Currency

USD

Showing 206 of 206 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001728117
Company name	Gossamer Bio, Inc.
Country	United States
Country code	US
Cusip	38341P102
Employees	162
Employees Change	17%
Employees Change Percent	11.72
Enterprise value	$186.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2019-02-08
Isin	US38341P1021
Last refreshed	2026-07-31
Market cap	$87.2M
Market cap category	Micro-Cap
Price	$0.18
Price currency	USD
Rev Per Employee	342,820.99x
Sector	Healthcare
Sector PE	45.56
Sector PE Fwd	24.38
Sic	2834
Symbol	GOSS
Website	https://www.gossamerbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-216.82%
EV Sales Forward	9.93x
EV/Sales	3.37x
FCF yield	-204.7%
P/S ratio	1.5x
PS Forward	4.42x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-69.8%
EBITDA Margin	-68.19%
Gross margin	100%
Gross Profit	$55.5M
Gross Profit Growth	-55.42%
Gross Profit Growth Q	71.45%
Net Income	$-180.4M
Net Income Growth Years	0%
Pretax Margin	-324.98%
Profit Per Employee	$-1.1M
ROA	-52.29
Roa5y	-33.18
ROCE	-53.55
ROIC	-89.98

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-90.92%
Cagr3y	-48.15%
Cagr5y	-53.05%
EPS Growth Years	0
Revenue Growth	-55.42x
Revenue Growth Q	71.45x
Revenue Growth Quarters	3x
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.27
Assets	$128.9M
Cash	$99.2M
Current Assets	$124.5M
Current Liabilities	$56.5M
Debt	$202.9M
Equity	$-161.5M
Interest Coverage	-3.52
Liabilities	$290.4M
Long Term Assets	$4.4M
Long Term Liabilities	$233.9M
Net Cash	$-103.7M
Net Cash By Market Cap	$-125
Tangible Book Value	$-161.5M
Tangible Book Value Per Share	$-0.69
WACC	7.54

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.2
Net Working Capital	$-30.2M
Quick ratio	1.92
Working Capital	$68M
Working Capital Turnover	$0.38

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.7%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-90.9%
200-day SMA	1.4
3Y total return	-86.07%
50-day SMA	0.18
50-day SMA vs 200-day SMA	50under200
5Y total return	-97.72%
All Time High	27.15
All Time High Change	-99.34%
All Time High Date	2019-12-12
All Time Low	0.11
All Time Low Change	56.68%
All Time Low Date	2026-07-14
ATR	0.03
Beta	2.04
Beta1y	1.79
Beta2y	1.48
Ch YTD	-94.25
High	0.21
High52	3.87
High52 Date	2025-12-15
High52ch	-95.39%
Low	0.17
Low52	0.11
Low52 Date	2026-07-14
Low52ch	56.68%
Ma50ch	1.02%
Premarket Change Percent	-1.21
Premarket Price	$0.2
Premarket Volume	808,846
Price vs 200-day SMA	-87.25%
RSI	50.83
RSI Monthly	36.2
RSI Weekly	28.12
Sharpe ratio	-0.67x
Sortino ratio	-0.8
Total Return	-1.7%
Tr YTD	-94.25
Tr1m	8.72%
Tr1w	25.12%
Tr3m	-49%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	7
Analyst Count Top	5
Analyst Price Target Top	$3.9
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.11
Earnings Revenue Estimate	4,516,400x
Earnings Revenue Estimate Growth	-60.69x
Operating Income	$-171.3M
Operating margin	-308.5
Price target	$3.86
Price Target Change	$2,065
Price Target Change Top	$2,087

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	313,162,091%
Float Percent	64.06%
Shares Insiders	1.54%
Shares Institutions	33.92%
Shares Out	488,846,722
Shares Qo Q	3.32%
Shares Yo Y	1.7%
Short Float	23.37%
Short Ratio	4.03
Short Shares	14.97

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-184.8M
Adjusted OCF	-184,717,000
Average Volume	42,310,498.75x
Bv Per Share	-0.69
CAPEX	$-53,000
Ch1m	8.72
Ch1w	25.12
Ch1y	-90.9
Ch3m	-49
Ch3y	-86.07
Ch5y	-97.72
Ch6m	-92.63
Change	-13.74%
Change From Open	-12.68
Close	0.21
Days Gap	-1.21
Depreciation Amortization	23,000
Dollar Volume	5,463,576.5
Earnings Date	2026-08-07
Earnings Time	amc
EBIT	$-38.8M
EBITDA	$-37.9M
EPS	$-0.78
F Score	1
FCF	$-170.3M
FCF EV Yield	-91.12x
FCF Per Share	$-0.35
Financing CF	6,433,000
Fiscal Year End	December
Founded	2,015
Income Tax	$-88,000
Investing CF	175,902,000
Ipr	-98.94
Iprfo	-99.1
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-15
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-17
Ma150	0.91
Ma150ch	-80.35%
Ma20	0.17
Ma20ch	6.32%
Net CF	12,007,000
Next Earnings Date	2026-08-11
Open	0.2
Optionable	Yes
Position In Range	28.15
Post Close	0.18
Postmarket Change Percent	-0.11
Postmarket Price	$0.18
Ppne	3,965,000
Pre Close	0.21
Price Date	2026-07-30
Relative Volume	0.72x
Revenue	55,537,000x
SBC By Revenue	26.03x
Share Based Comp	14,454,000
Tax By Revenue	-0.16x
Tr6m	-92.63%
Us State	California
Views	276
Volume	30,642,605
Z Score	-18.54

Gossamer Bio, Inc. (GOSS)

Coverage state: Market snapshot only — no published research

Generate the first GOSS analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · GOSS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All GOSS indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on GOSS

Frequently asked questions